openPR Logo
Press release

In Vitro Diagnostics Market Size, Share, Growth and Trends, Report 2024-2031

09-09-2024 02:16 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

In Vitro Diagnostics Market || 2024-2031

In Vitro Diagnostics Market || 2024-2031

Global In Vitro Diagnostics Market reached US$ 98.3 billion in 2023 and is expected to reach US$ 145.7 billion by 2031, growing at a CAGR of 5.3% during the forecast period 2024-2031.

In Vitro Diagnostics (IVD) involves tests conducted on human samples to detect diseases, conditions, or infections, typically performed outside the body in laboratory settings with advanced instruments and reagents. IVD plays a vital role in modern medicine by supplying essential information for diagnosing diseases, making treatment decisions, and monitoring patient health. The IVD market is expanding rapidly, driven by technological advancements, an aging global population, increasing prevalence of chronic diseases, and the rising demand for personalized medicine.

Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market

Market Dynamics:

Rise in technological advancements

Technological advancements are significantly contributing to the growth of the IVD market during the forecast period. Molecular diagnostics, such as PCR and NGS, enable early detection of genetic diseases, enhancing diagnostic accuracy and treatment outcomes. Point-of-care testing devices facilitate quicker diagnoses and treatments, particularly in remote areas. Automation and digitalization in IVD systems boost efficiency, minimize human error, and deliver more accurate results, especially in remote settings. The introduction of novel and highly accurate clinical laboratory tests is driving the global adoption of innovative IVD tests. For example, in June 2023, Toray Industries, Inc. obtained marketing approval from Japan's Ministry of Health, Labour and Welfare for its Toray APOA2-iTQ, a diagnostic tool for pancreatic cancer. Additionally, in March 2023, Abbott received U.S. FDA clearance for its new traumatic brain injury (TBI) blood test. The increasing approval of IVD tests for life-threatening diseases is expected to open new opportunities in previously untapped markets.

Segment Covered in the In Vitro Diagnostics Market:

By Product: Instruments, Reagents, Software and Services.

By Technique: Immunoassays, POC diagnostics, Molecular diagnostics, Hematology, Tissue diagnostics, Microbiology, Self-Blood-Glucose Monitoring, Others.

By Application: Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, Others.

By End User: Diagnostic Laboratories, Hospitals, Academics and Research Institutes, Others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/parenteral-nutrition-market

Key players involved in the In Vitro Diagnostics Market:

• BioMérieux
• Danaher Corporation
• Roche Diagnostics
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Bayer AG
• Arkray, Inc
• Sysmex Corporation
• Siemens AG

Related Reports:

Metabolomics Market: https://www.datamintelligence.com/research-report/metabolomics-market

Dermatology Devices Market: https://www.datamintelligence.com/research-report/dermatology-devices-market

Drug of Abuse Testing Market: https://www.datamintelligence.com/research-report/drug-of-abuse-testing-market

Regional Analysis:

The In Vitro Diagnostics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The In Vitro Diagnostics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Diagnostics Market Size, Share, Growth and Trends, Report 2024-2031 here

News-ID: 3649683 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Diagnostic

Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804 This latest report researches the industry structure, sales, revenue,
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688 This latest report researches the industry structure, sales, revenue,
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends